|
TVIS44024967
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
134922106 |
134922106 |
q22.2 |
ENSG00000288700, EPHB1 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44024968
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
137453962 |
137453962 |
q22.3 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44024969
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
138604878 |
138604878 |
q22.3 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44024970
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
13862756 |
13862756 |
p25.1 |
WNT7A |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44024971
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
139906877 |
139906877 |
q23 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44024972
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
140272627 |
140272627 |
q23 |
CLSTN2 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44024973
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
140400975 |
140400975 |
q23 |
CLSTN2 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44024974
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
140400975 |
140400975 |
q23 |
CLSTN2 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44024975
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
141054267 |
141054267 |
q23 |
SPSB4 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44024976
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr3 |
141054267 |
141054267 |
q23 |
SPSB4 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |